InMed Pharmaceuticals Inc. — Director's Dealing 2024

May 28, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InMed Pharmaceuticals Inc. (INM)
CIK: 0001728328
Period of Report: 2024-05-27

Reporting Person: MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-27	Employee Stock Option (Expiration)	$263.18	H	485	Disposed	2024-05-27	Common shares (485)	Direct

Footnotes

F1: Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00